Merck Crixivan Label Adds Pregnancy Precaution
This article was originally published in The Pink Sheet Daily
Executive Summary
Precaution is based on a 16-patient study showing decreased plasma concentration. Crixivan remains a pregnancy category C drug and becomes the only protease inhibitor to include pharmacokinetic data for pregnant women.